Detalles de la búsqueda
1.
Phase I clinical and pharmacology study of topotecan given daily for 5 consecutive days to patients with advanced solid tumors, with attempt at dose intensification using recombinant granulocyte colony-stimulating factor.
J Natl Cancer Inst
; 85(18): 1499-507, 1993 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-7689654
Resultados
1 -
1
de 1
1
Próxima >
>>